Beyond Verbal is an innovative company at the intersection of AI and healthcare, founded in 2012. Its core technology harnesses the power of voice and artificial intelligence to identify human emotions and detect Vocal Biomarkers—unique acoustic traits indicative of various health issues.
The company’s efforts are bolstered by partnerships with prominent medical institutions that propel its numerous clinical trials and data projects to uncover indicators of cardiovascular, pulmonary, neurological, and other diseases through voice analysis. These technological capabilities facilitate ongoing patient monitoring and predictive analytics, positioning Beyond Verbal as a leader in the health tech space.
Beyond Verbal’s last recorded financial backing was a $3.00M Series A investment in September 2016, with contributions from investors such as Singulariteam, Kuang-Chi Science, and Winnovation. The company operates in diverse industries, including AI, Analytics, Big Data, Computing, Health Care, and Machine Learning.
